DEREK T CHALMERS Insider Trading $CARA Cara Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEREK T CHALMERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEREK T CHALMERS. DEREK T CHALMERS is in ARENA PHARMACEUTICALS INC ($ARNA) and President & CEO in Cara Therapeutics, Inc. ($CARA).
DEREK T CHALMERS in Cara Therapeutics, Inc.
Trading Symbol: CARAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEREK T CHALMERS: President & CEO
Holdings: 1,002,511 shares
Current Value: $16,340,929
Latest Transaction: Apr 01 2021
$CARA Market Capitalization: $449.33M
$CARA Previous Close: $16.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DEREK T CHALMERS in Cara Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 20.59 | 103,000 | 2,120,770 | 103,000 | |
Apr 01 2021 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 52,000 | 0 | 1,002,511 | 950.5 K to 1 M (+5.47 %) |
Mar 08 2021 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 17.98 | 3,103 | 55,792 | 950,511 | 953.6 K to 950.5 K (-0.33 %) |
Mar 08 2021 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 10,000 | 0 | 953,614 | 943.6 K to 953.6 K (+1.06 %) |
Feb 25 2021 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 19.33 | 11,729 | 226,722 | 943,614 | 955.3 K to 943.6 K (-1.23 %) |
Feb 25 2021 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 18,750 | 0 | 955,343 | 936.6 K to 955.3 K (+2.00 %) |
Dec 30 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 15.30 | 6,078 | 92,993 | 936,593 | 942.7 K to 936.6 K (-0.64 %) |
Dec 29 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 5,000 | 80,000 | 942,671 | 947.7 K to 942.7 K (-0.53 %) |
Dec 29 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 18,750 | 0 | 947,671 | 928.9 K to 947.7 K (+2.02 %) |
Dec 18 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 14.95 | 5,000 | 74,750 | 928,921 | 933.9 K to 928.9 K (-0.54 %) |
Dec 11 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 15.29 | 7,500 | 114,675 | 933,921 | 941.4 K to 933.9 K (-0.80 %) |
Nov 19 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 11,799 | 188,784 | 941,421 | 953.2 K to 941.4 K (-1.24 %) |
Sep 08 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 3,201 | 51,216 | 953,220 | 956.4 K to 953.2 K (-0.33 %) |
Aug 05 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.42 | 5,000 | 82,100 | 956,421 | 961.4 K to 956.4 K (-0.52 %) |
Jun 03 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.01 | 4,300 | 68,843 | 966,421 | 970.7 K to 966.4 K (-0.44 %) |
Jun 03 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 700 | 11,200 | 970,721 | 971.4 K to 970.7 K (-0.07 %) |
May 22 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 371 | 5,936 | 971,421 | 971.8 K to 971.4 K (-0.04 %) |
May 22 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 3,500 | 56,000 | 971,792 | 975.3 K to 971.8 K (-0.36 %) |
May 22 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 1,200 | 19,200 | 975,292 | 976.5 K to 975.3 K (-0.12 %) |
May 14 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.00 | 4,929 | 78,864 | 976,492 | 981.4 K to 976.5 K (-0.50 %) |
Apr 21 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 15.56 | 6,348 | 98,775 | 981,421 | 987.8 K to 981.4 K (-0.64 %) |
Apr 21 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 20,000 | 0 | 987,769 | 967.8 K to 987.8 K (+2.07 %) |
Feb 26 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 16.36 | 100,000 | 1,636,000 | 100,000 | |
Feb 26 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 50,000 | 0 | 967,769 | 917.8 K to 967.8 K (+5.45 %) |
Jan 06 2020 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 16.05 | 10,000 | 160,500 | 917,769 | 927.8 K to 917.8 K (-1.08 %) |
Dec 04 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 17.05 | 10,699 | 182,418 | 927,769 | 938.5 K to 927.8 K (-1.14 %) |
Dec 04 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 20,000 | 0 | 938,468 | 918.5 K to 938.5 K (+2.18 %) |
Dec 04 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 25.79 | 10,000 | 257,900 | 918,468 | 928.5 K to 918.5 K (-1.08 %) |
Nov 05 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 20.79 | 5,000 | 103,950 | 928,468 | 933.5 K to 928.5 K (-0.54 %) |
Oct 03 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 18.28 | 10,000 | 182,800 | 933,468 | 943.5 K to 933.5 K (-1.06 %) |
Sep 05 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 23.26 | 5,000 | 116,300 | 943,468 | 948.5 K to 943.5 K (-0.53 %) |
Aug 05 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 23.27 | 10,000 | 232,700 | 948,468 | 958.5 K to 948.5 K (-1.04 %) |
May 30 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 21.42 | 5,528 | 118,410 | 958,468 | 964 K to 958.5 K (-0.57 %) |
May 30 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 20,000 | 0 | 963,996 | 944 K to 964 K (+2.12 %) |
Mar 08 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 16.10 | 235,000 | 3,783,500 | 235,000 | |
Mar 05 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 17.04 | 9,792 | 166,856 | 943,996 | 953.8 K to 944 K (-1.03 %) |
Feb 05 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 14.99 | 20,000 | 299,800 | 953,788 | 973.8 K to 953.8 K (-2.05 %) |
Jan 04 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 15.04 | 5,000 | 75,200 | 973,788 | 978.8 K to 973.8 K (-0.51 %) |
Jan 04 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 13.13 | 15,000 | 196,950 | 978,788 | 993.8 K to 978.8 K (-1.51 %) |
Jan 02 2019 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 12.53 | 15,825 | 198,287 | 993,788 | 1 M to 993.8 K (-1.57 %) |
Dec 31 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Grant | A | 0.00 | 38,221 | 0 | 1,009,613 | 971.4 K to 1 M (+3.93 %) |
Dec 06 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 18.17 | 20,000 | 363,400 | 971,392 | 991.4 K to 971.4 K (-2.02 %) |
Nov 02 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 18.78 | 20,000 | 375,600 | 991,392 | 1 M to 991.4 K (-1.98 %) |
Oct 03 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 23.79 | 20,000 | 475,800 | 1,011,392 | 1 M to 1 M (-1.94 %) |
Sep 06 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 19.71 | 20,000 | 394,200 | 1,031,392 | 1.1 M to 1 M (-1.90 %) |
Jul 12 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 20.64 | 20,000 | 412,800 | 1,051,392 | 1.1 M to 1.1 M (-1.87 %) |
Mar 13 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 14.39 | 187,500 | 2,698,125 | 187,500 | |
Feb 21 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 15.00 | 5,400 | 81,000 | 1,071,392 | 1.1 M to 1.1 M (-0.50 %) |
Jan 26 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | M | 6.00 | 3,000 | 18,000 | 191,000 | |
Jan 26 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Buy | M | 6.00 | 3,000 | 18,000 | 1,076,792 | 1.1 M to 1.1 M (+0.28 %) |
Jan 26 2018 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 15.00 | 12,500 | 187,500 | 1,073,792 | 1.1 M to 1.1 M (-1.15 %) |
Nov 03 2017 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | M | 2.48 | 20,000 | 49,600 | 0 | |
Nov 03 2017 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Buy | M | 2.48 | 20,000 | 49,600 | 1,086,292 | 1.1 M to 1.1 M (+1.88 %) |
Nov 03 2017 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 12.66 | 16,000 | 202,560 | 1,066,292 | 1.1 M to 1.1 M (-1.48 %) |
Jul 18 2017 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | M | 2.48 | 10,000 | 24,800 | 20,000 | |
Jul 18 2017 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 15.05 | 25,000 | 376,250 | 1,082,292 | 1.1 M to 1.1 M (-2.26 %) |
Jul 18 2017 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Buy | M | 2.48 | 10,000 | 24,800 | 1,107,292 | 1.1 M to 1.1 M (+0.91 %) |
Mar 10 2017 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 17.41 | 225,000 | 3,917,250 | 225,000 | |
Apr 01 2016 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 6.00 | 194,000 | 1,164,000 | 194,000 | |
Mar 17 2016 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | M | 2.48 | 10,000 | 24,800 | 30,000 | |
Mar 17 2016 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Buy | M | 2.48 | 10,000 | 24,800 | 1,097,292 | 1.1 M to 1.1 M (+0.92 %) |
Jan 07 2016 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Sell | S | 17.22 | 12,500 | 215,250 | 1,087,292 | 1.1 M to 1.1 M (-1.14 %) |
Jun 17 2015 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 10.82 | 165,000 | 1,785,300 | 165,000 |
Page: 1